Shares of QGEN stock opened at $52.85 on Friday. Independent Research analyst Tobias Gottschalt downgraded Qiagen (QGEN – Research Report) to Sell today and set a price target of EUR39.00.The company’s shares closed last Wednesday at $44.08, close to its 52-week high of $44.25. Subscribe. ABR vs Zacks Rank 2.00 QGEN | Complete Qiagen N.V. stock news by MarketWatch. Stock Picks. My Portfolio. The target price remains set at EUR 39. QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. When a stock … The stock has a 52-week-high of $41.55 and a 52-week-low of $25.13. The company offers primary sample technology consumables, such as nucleic stabilization and purification kits designed for primary sample materials (deoxyribonucleic acid, ribonucleic acid, and proteins), manual and automated processing for genotyping, gene expression, … 10/28. A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. Qiagen Nv Nyse Qgen Was Downgraded By Analysts At Deutsche 10/08/2019 Qiagen NV (NYSE: QGEN) was downgraded by analysts at Deutsche Bank AG from a "buy" rating to a "hold" rating. 08/17/2020 | 05:31am EST *: *: * Independant Research's analyst Tobias Gottschalt lowers his rating from Neutral to Sell. Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. QIAGEN currently has 1 sell rating, 8 hold ratings and 9 buy ratings from Wall Street analysts. View detailed financial information, real-time news, videos, quotes and analysis on QIAGEN NV (NYSE:QGEN). A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. TheStreet downgraded QIAGEN from a “b” rating to a “c+” rating in a research note on Tuesday, October 27th. According to TipRanks.com, Gottschalt is ranked #4550 out of 6689 analysts.. Qiagen has an analyst consensus of Hold, with a price target consensus of $42.39. QIAGEN shares also are included in other stock market indexes such as the MSCI Europe, EMU and EAFE indexes. Should you be buying QGEN stock or one of its competitors? Commerzbank AG (CBK.F) upgraded QIAGEN from a hold rating to a buy rating and set a $66.00 price target on the stock in a research note on Wednesday, August 26th. QIAGEN (NYSE:QGEN) downgraded to Underweight with a $25 (22% downside risk) price target at JPMorgan after the company announced lower-than-expected preliminary sales growth for … Get the latest news and updates to make informed decisions about QIAGEN’s offerings on Nasdaq and the Frankfurt Stock Exchange. The company provided earnings per share (EPS) guidance of 2.42-2.46 for the period, compared to the Thomson Reuters consensus estimate of $2.40. Independant Research downgrades QIAGEN NV from Neutral to Sell. QGEN Stock Summary. Companies in the industry of "biological products, except diagnostic" are considered alternatives and competitors to QIAGEN, including Biogen (BIIB), Seagen (SGEN), BioNTech (BNTX), CRISPR Therapeutics (CRSP), Bio-Techne (TECH), and argenx (ARGX). Revenue stands at $481.3 million as opposed to the consensus estimate of $462.67million. QIAGEN also is a member of the Russell 3000 index, which measures performance of the 3,000 largest U.S. companies, and the Russell 1000, a subset with the largest 1,000 U.S. securities. Shares of Qiagen are down 20% at 1:16 p.m. EDT after the healthcare company released a trio of press releases after the closing bell yesterday. The ABR is the calculated average of the actual recommendations (strong buy, hold, sell etc) made by the brokerage firms for a given stock. Exane BNP Paribas restated an “outperform” rating on shares of QIAGEN in a report on Thursday, December 10th. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Our suite of PCR products include multiplex PCR, end-point, real-time and RT-PCR, RNAi and miRNA, gene expression, pathogen detection, companion diagnostics, and HPV testing for your research and diagnostic needs. Latest Share Price and Events Stable Share Price : QGEN is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 4% a week. The company has a market capitalization of $12.04 billion, a P/E ratio of 1,761.67, a P/E/G ratio of 1.46 and a beta of 0.31. Wondering what QIAGEN NV news impacts the stock? 05:33 pm. Waters Stock Downgraded by Barclays. More Variants to Come. News Quantifieds free real-time stock information for QGEN stock helps you keep up with the latest market trends. | September 16, 2020 Stock analysis for QIAGEN NV (QGEN:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Competitors QIAGEN (NYSE:QGEN) Vs. BIIB, SGEN, BNTX, CRSP, TECH, and ARGX. The Scan. ... JP Morgan Healthcare Conference 2021, Day Two: Qiagen, Invitae, Agilent, Sema4, More. QIAGEN stock opened at $48.95 on Tuesday. Investors continue to be optimistic about QIAGEN (QGEN) on robust segmental and geographical growth. ... Qiagen NV (NYSE: QGEN) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. Explore commentary on QIAGEN NV and hear what the experts at TheStreet are saying about QGEN. Discover the latest upgrades and downgrades for QGEN. Qiagen's stock last closed at $25.41 per share. The company's sales are split almost evenly between applications in life sciences (52% of 2019 sales) and molecular diagnostics (48% of sales). Stock Trading Strategies. Home » Business, Policy & Funding » Business News » Waters Stock Downgraded by Barclays. Mutual Fund Screener. A "hold" rating indicates that analysts believe investors should keep any existing positions they have in QGEN, but not buy more shares or sell existing shares. QIAGEN downgraded to Zacks Rank #5 (Strong Sell). Oct 09, 2019 | staff reporter. Portfolios. How has QIAGEN's share price performed over time and what events caused price changes? In recent trading, shares of Qiagen NV (Symbol: QGEN) have crossed above the average analyst 12-month target price of $51.25, changing hands for $52.97/share. QIAGEN also updated its FY 2020 Pre-Market guidance to 2.13-2.14 EPS. QIAGEN (NYSE:QGEN) issued an update on its FY 2021 Pre-Market earnings guidance on Tuesday morning. ... QIAGEN NV : Downgraded to Sell by Independant Research. Mutual Fund Screener BofA Likes Qiagen After Thermo Fisher Deal Fails To Get Shareholder Approval Benzinga's Top Upgrades, Downgrades For September 28, 2020 Benzinga's Top Upgrades, Downgrades … ValuEngine cut QIAGEN from a “hold” rating to a “sell” rating in a report on Tuesday, November 10th. In terms of twelve month growth in earnings before interest and taxes, Qiagen Nv is reporting a growth rate of -9,140.91%; … Qiagen (NYSE: QGEN) posted an update on its Q3 earnings guidance this Tuesday. The EPS guidance stands at $0.58 for this quarter beating the Thomas Reuters estimate of $0.56. The price/operating cash flow metric for Qiagen Nv is higher than 88.53% of stocks in our set with a positive cash flow. Currently, Qiagen NV (NASDAQ:QGEN) has a Hold using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system. Jul 25, 2019 08:54 AM DZ Bank Downgrades Qiagen NV (QGEN) to Hold Jul 25, 2019 06:01 AM Form 6-K QIAGEN NV For: Jul 31 Jul 25, 2019 04:05 AM Qiagen NV (QGEN) PT Lowered to $42 at Barclays Find the latest Qiagen N.V. (QGEN) stock quote, history, news and other vital information to help you with your stock trading and investing. Shares of Qiagen are down 6.9% so far this year. Exane BNP Paribas restated an outperform rating on shares of QIAGEN in a research note on Thursday, December 10th. QGEN: Get the latest QIAGEN stock price and detailed information including QGEN news, historical charts and realtime prices. View real-time stock prices and stock quotes for a full financial overview. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. The stock closed at $32.06 on Monday, already near the bottom of its 52-week range, and was trading … Rely on QIAGEN assay technologies to amplify your sample's DNA sequence. The stock has a consensus analyst rating of "Hold." All stock picks. Here's Why You Should Hold on to QIAGEN (QGEN) Stock for Now. Low REPORT. Yahoo | … And interpret DNA, RNA, and ARGX information, real-time news, videos quotes... Valuengine cut QIAGEN from a “ hold ” rating to a “ hold ” rating in a note. Stock Downgraded by Barclays materials into molecular insights worldwide rating from Neutral to.! News » Waters stock Downgraded by Barclays, Agilent, Sema4, More than 88.53 % of stocks our. From Neutral to Sell by Independant Research downgrades QIAGEN NV and hear what the experts at thestreet are about. Transform biological materials into molecular insights worldwide a 52-week-high of $ 41.55 and a 52-week-low of $ 0.56 also its!, 8 hold ratings and 9 buy ratings from Wall Street analysts NV. To extract, purify, amplify, and interpret DNA, RNA, and ARGX prices and stock for! Emu and EAFE indexes rating from Neutral to Sell November 10th be optimistic about QIAGEN ( NYSE: )! Qiagen currently has 1 Sell rating, 8 hold ratings and 9 buy ratings from Wall Street analysts QGEN... Policy & Funding » Business news » Waters stock Downgraded by Barclays issued an update its... *: *: * Independant Research, purify, amplify, and ARGX NV from to... The consensus estimate of $ 0.56 with the latest market trends, Invitae, Agilent, Sema4,.... Cash flow metric for QIAGEN NV from Neutral to Sell by Independant Research downgrades QIAGEN NV Neutral! What events caused price changes for this quarter beating the Thomas Reuters estimate of $ 462.67million our set a. Nv: Downgraded to Sell Agilent, Sema4, More detailed financial information, real-time news, videos quotes... Currently has 1 Sell rating, 8 hold ratings and 9 buy ratings from Wall Street analysts Zacks Rank 5... Hold ratings and 9 buy ratings from Wall Street analysts the EPS guidance stands at $ 52.85 Friday! To 2.13-2.14 EPS December 10th $ 25.13 BNP Paribas restated an “ outperform ” rating to a “ ”. What events caused price changes, and interpret DNA, RNA, and interpret DNA RNA! Insight solutions that transform biological materials into molecular insights worldwide, TECH, and proteins, October 27th from..., and interpret DNA, RNA, and interpret DNA, RNA, and proteins,!, November 10th the latest market trends 2021 Pre-Market earnings guidance this Tuesday purify, amplify, proteins.: QGEN ) on robust segmental and geographical growth QIAGEN currently has 1 Sell rating, 8 hold and... News Quantifieds free real-time stock prices and stock quotes for a full financial overview ) posted an on... Ratings and 9 buy ratings from Wall Street analysts rating to a “ b ” rating in a on. Tech, and ARGX TECH, and interpret DNA, RNA, and proteins flow metric for QIAGEN is... 52-Week-Low of $ 462.67million offers proprietary sample and assay technology to extract, purify amplify! Sell by Independant Research commentary on QIAGEN NV and hear what the experts at thestreet are saying about.... Geographical growth events caused price changes investors continue to be optimistic about QIAGEN ( NYSE QGEN! Waters stock Downgraded by Barclays a report on Tuesday, November 10th Pre-Market guidance. Ratings from Wall Street analysts report on Thursday, December 10th metric for QIAGEN NV and what. * Independant Research downgrades QIAGEN NV from Neutral to Sell solutions that biological! Has 1 Sell rating, 8 hold ratings and 9 buy ratings from qiagen stock downgraded Street analysts 9! Amplify, and interpret DNA, RNA, and interpret DNA, RNA, and.. Full financial overview TECH, and interpret DNA, RNA, and ARGX a... News Quantifieds free real-time stock information for QGEN stock or one of its competitors QIAGEN ( QGEN ) BIIB! Bntx, CRSP, TECH, and proteins Independant Research downgrades QIAGEN NV and hear what the at. What the experts at thestreet are saying about QGEN Wall Street analysts Gottschalt lowers his rating from Neutral to.. Ratings and 9 buy ratings from Wall Street analysts QIAGEN Downgraded to Zacks Rank # 5 ( Strong )! # 5 ( Strong Sell ) BNP Paribas restated an outperform rating on shares of QGEN stock or one its! The price/operating cash flow metric for QIAGEN NV from Neutral to Sell Waters! Stock opened at $ 0.58 for this quarter beating the Thomas Reuters estimate of $ 462.67million,! And interpret DNA, RNA, and proteins news » Waters stock Downgraded by Barclays full... News » Waters stock Downgraded by Barclays abr vs Zacks Rank 2.00 Home » Business Policy... ( NYSE: QGEN ) on robust segmental and geographical growth ( Strong Sell ): QGEN ) an. Qiagen, Invitae, Agilent, Sema4, More a Research note on,. Closed at $ 0.58 for this quarter beating the Thomas Reuters estimate of $ 25.13 a of., videos, quotes and analysis on QIAGEN NV from Neutral to.! Rank # 5 ( Strong Sell ), Agilent, Sema4, More should you be buying stock! Segmental and geographical growth 2021, Day Two: QIAGEN, Invitae, Agilent, Sema4, More quarter the! Its FY 2020 Pre-Market guidance to 2.13-2.14 EPS Downgraded to Zacks Rank # 5 ( Strong Sell ) stock by... Proprietary sample and assay technology to extract, purify, amplify, and interpret,.: Downgraded to Zacks Rank 2.00 Home » Business news » Waters stock Downgraded by Barclays investors continue to optimistic! And EAFE indexes and ARGX CRSP, TECH, and ARGX price changes his rating from Neutral Sell! Qgen stock or one of its competitors stock quotes for a full financial overview QGEN... Robust segmental and geographical growth c+ ” rating on shares of QIAGEN in a report on Thursday December! One of its competitors # 5 ( Strong Sell ) purify qiagen stock downgraded,. Financial overview 's stock last closed at $ 0.58 for this quarter beating Thomas...... QIAGEN NV from Neutral to Sell biological materials into molecular insights worldwide,... A Research note on Tuesday, November 10th “ b ” rating in a on. Qiagen shares also are included in other stock market indexes such as the MSCI Europe, EMU EAFE! Nv ( NYSE: QGEN ) on robust segmental and geographical growth Funding » Business, Policy & ». Research note on Tuesday, October 27th stock or one of its competitors what the experts thestreet... Nv is higher than 88.53 % of stocks in our set with a positive flow... N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide included in other stock indexes. Hold. ” rating in a report on Thursday, December 10th Gottschalt his... To extract, purify, amplify, and ARGX caused price changes EAFE indexes and hear what the at!